CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Venmax Drugs and Pharmaceuticals Ltd

Venmax Drugs and Pharmaceuticals Ltd

BSE 531015 VENMAX INE154G01022
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

7 filings · 2 material · busiest 2026-08-07

What it files

Allotment2 Board Meeting1 Board Outcome1 Results1 Other Update1 Compliance Certificate1

Filings

7 in the window

  1. 24 August 2026

    Board Meeting

    Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Venmax Drugs And Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 ,inter alia, to consider and approve matters related ....

    Board Meeting / Board Meeting View filing →

  2. 7 August 2026

    Board Outcome

    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.

    Unaudited Standalone Financial Results along with the Limited Review Report For the Quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  3. 7 August 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026.

    Unaudited Financial Results along with Limited Review Report for the Quarter ended June 30, 2026.

    Result / Financial Results View filing →

  4. 7 August 2026

    Other Update

    Statement Of Deviation & Variation

    Statement of Deviation & Variation for the Quarter ended June 30, 2026.

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  5. 30 July 2026

    Allotment

    Allotment

    Allotment of 7,53,334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation, 2015.

    Company Update / Allotment of Equity Shares View filing →

  6. 29 July 2026

    Allotment

    Allotment

    Allotment of 21,47,665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation, 2015.

    Company Update / Allotment of Equity Shares View filing →

  7. 14 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →